drugset / Trial / NCT01689038

Brain Imaging Study of F17464

NCT01689038 ↗

Phase 1 Completed 8 enrolled Pierre Fabre Laboratories
NaSingle-groupOpen-labelBasic science

Summary

Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.

Timeline

Start
2012-11
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject F17464 Small molecule — —

Indications

No indication recorded.